Which has grown faster, AMRX or CRSP?

Over the past five years, CRSP grew revenue faster — AMRX at a 8.67% CAGR versus CRSP at 37.32%.

Is AMRX or CRSP more profitable?

AMRX runs the higher net margin — AMRX at 5.05% versus CRSP at -3368.72%.

How have AMRX and CRSP total returns compared?

Over the past 5 years, AMRX delivered 30.25% and CRSP delivered -11.94% annualized total return. Past performance doesn't predict future results.

Amneal Pharmaceuticals, Inc. (AMRX) vs CRISPR Therapeutics AG (CRSP)

A side-by-side comparison of Amneal Pharmaceuticals, Inc. and CRISPR Therapeutics AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AMRX

Amneal Pharmaceuticals, Inc.

$6.48B

$20.30HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

CRSP

CRISPR Therapeutics AG

$5.21B

$54.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — AMRX vs CRSP

growth of $100 · dividends reinvested · last 10y

AMRX -6.2% (-0.6%/yr)CRSP +307.0% (+15.1%/yr)CRSP compounded faster over this window

AMRX CRSP

AMRX vs CRSP: by the numbers

•AMRX is the larger company ($6.48B vs $5.21B market cap).
•AMRX is profitable (5.05% net margin) while CRSP runs a net loss (-3368.72%).
•CRSP grew revenue faster over the past five years (37.32% vs 8.67% CAGR).

Metrics side by side

Valuation

Metric	AMRX	CRSP
P/E ratio	41.63	N/A
Forward P/E	19.82	N/A
P/S ratio	2.08	388.91
P/B ratio	196.25	2.98
EV / EBITDA	15.30	N/A
FCF yield	1.28%	N/A

Profitability

Metric	AMRX	CRSP
Gross margin	39.32%	-6537.01%
Operating margin	12.93%	-16191.40%
Net margin	5.05%	-3368.72%
ROE	476.51%	-25.83%
ROIC	13.45%	-21.12%

Growth (annualized)

Metric	AMRX	CRSP
Revenue CAGR (5Y)	8.67%	37.32%
EPS CAGR (5Y)	-17.72%	N/A
FCF CAGR (5Y)	-14.46%	N/A
Total return CAGR (5Y)	30.25%	-11.94%

Frequently asked

Which has grown faster, AMRX or CRSP?: Over the past five years, CRSP grew revenue faster — AMRX at a 8.67% CAGR versus CRSP at 37.32%.
Is AMRX or CRSP more profitable?: AMRX runs the higher net margin — AMRX at 5.05% versus CRSP at -3368.72%.
How have AMRX and CRSP total returns compared?: Over the past 5 years, AMRX delivered 30.25% and CRSP delivered -11.94% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AMRX analysis Full CRSP analysis Interactive comparison tool

Dig into the metrics

Amneal Pharmaceuticals P/E ratio Amneal Pharmaceuticals ROE CRISPR Therapeutics AG ROE Amneal Pharmaceuticals operating margin CRISPR Therapeutics AG operating margin Amneal Pharmaceuticals revenue growth CRISPR Therapeutics AG revenue growth Amneal Pharmaceuticals free cash flow CRISPR Therapeutics AG free cash flow

Amneal Pharmaceuticals & CRISPR Therapeutics AG appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.